These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18064343)

  • 1. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
    McNicol A; Eyer E; Jackson EC; Israels SJ
    Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
    [No Abstract]   [Full Text] [Related]  

  • 2. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.
    Nurden P; Lanza F; Bonnafous-Faurie C; Nurden A
    Thromb Haemost; 2007 Feb; 97(2):319-21. PubMed ID: 17264965
    [No Abstract]   [Full Text] [Related]  

  • 3. The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system.
    Furman MI; Nurden P; Berndt MC; Nurden AT; Benoit SE; Barnard MR; Ofosu FA; Michelson AD
    Thromb Haemost; 2000 Nov; 84(5):897-903. PubMed ID: 11127874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
    Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
    Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
    Favaloro EJ
    Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
    [No Abstract]   [Full Text] [Related]  

  • 10. [von Willebrand disease type 1].
    Sugimoto M
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):476-8. PubMed ID: 9833547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Involvement of platelet collagen receptors in primary hemostasis].
    Kralisz U; Stasiak M
    Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young male smokers have altered platelets and endothelium that precedes atherosclerosis.
    Casey RG; Joyce M; Roche-Nagle G; Cox D; Bouchier-Hayes DJ
    J Surg Res; 2004 Feb; 116(2):227-33. PubMed ID: 15013360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functions of thrombin receptors in the reversible distribution of platelet surface glycoprotein I balpha in activated platelets].
    Han Y; Pasquet JM; Nurden A; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):152-6. PubMed ID: 15946527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin.
    Schlagenhauf A; Schweintzger S; Birner-Gruenberger R; Leschnik B; Muntean W
    Platelets; 2010; 21(8):641-7. PubMed ID: 20807173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
    Bonnefoy A; Vermylen J; Hoylaerts MF
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor.
    Pelkmans L; Miszta A; Al Dieri R; de Laat B; Kelchtermans H
    Thromb Haemost; 2015 Jan; 113(1):209-11. PubMed ID: 25274249
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
    Othman M
    Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycocalicin derived peptides inhibit von Willebrand factor binding to platelets.
    Williams SB; Krutzsch H; McKeown LP; Gralnick HR
    Thromb Res; 1997 Jun; 86(5):417-21. PubMed ID: 9211633
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.